,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny-04', 'bcsm']
wow destiny-04 t-dxd in her2-low metbc #asco22 #bcsm. standing ovation 
Cancer Research Patient Advocate at UNC Lineberger CCC. Breast & Liver cancer, clinical trials, PROMs, #SciComm Featured Voice #ASCO22 FCOI: https://t.co/PzlQKUfjUw